Markel (NYSE:MKL) was upgraded by research analysts at William Blair from a “market perform” rating to an “outperform” rating in a research note issued on Monday.
Several other analysts have also commented on MKL. SunTrust Banks increased their price objective on Markel to $1,200.00 and gave the company a “hold” rating in a report on Thursday, February 8th. Zacks Investment Research lowered Markel from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Royal Bank of Canada reiterated a “hold” rating and set a $1,200.00 price objective on shares of Markel in a report on Thursday, February 8th. Finally, ValuEngine lowered Markel from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. Markel presently has an average rating of “Hold” and an average price target of $1,172.00.
Shares of Markel stock opened at $1,182.13 on Monday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $16,115.45, a price-to-earnings ratio of 45.85 and a beta of 0.95. Markel has a twelve month low of $936.95 and a twelve month high of $1,194.98.
Markel (NYSE:MKL) last issued its quarterly earnings data on Tuesday, February 6th. The insurance provider reported $6.64 EPS for the quarter, missing the consensus estimate of $8.55 by ($1.91). Markel had a net margin of 6.52% and a return on equity of 0.39%. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.58 billion. equities analysts forecast that Markel will post 33.19 EPS for the current year.
In related news, insider Alan I. Kirshner sold 100 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $1,133.50, for a total value of $113,350.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Steven A. Markel sold 200 shares of the firm’s stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $1,132.73, for a total value of $226,546.00. Following the completion of the transaction, the insider now owns 107,210 shares of the company’s stock, valued at approximately $121,439,983.30. The disclosure for this sale can be found here. In the last quarter, insiders have sold 2,000 shares of company stock valued at $2,227,666. Company insiders own 2.53% of the company’s stock.
A number of hedge funds have recently modified their holdings of the stock. Ackerman Capital Advisors LLC acquired a new stake in Markel during the 4th quarter worth about $326,000. Xact Kapitalforvaltning AB grew its position in Markel by 18.3% during the 4th quarter. Xact Kapitalforvaltning AB now owns 1,323 shares of the insurance provider’s stock worth $1,507,000 after purchasing an additional 205 shares during the period. Envestnet Asset Management Inc. grew its position in Markel by 5.3% during the 4th quarter. Envestnet Asset Management Inc. now owns 5,151 shares of the insurance provider’s stock worth $5,868,000 after purchasing an additional 257 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Markel by 25.7% during the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 5,029 shares of the insurance provider’s stock worth $5,729,000 after purchasing an additional 1,027 shares during the period. Finally, MainStreet Investment Advisors LLC acquired a new stake in Markel during the 4th quarter worth about $944,000. Institutional investors own 78.12% of the company’s stock.
Markel Company Profile
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.